Molecular mechanism involved in the maintenance of pluripotent stem cells

Journal of Stem Cells

Volumn 6, Issue 4, 2011, Pages 213-232

  Wong, Raymond Ching Bong ^a   Donovan, Peter J ^a,b   Pébay, Alice ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Australia and Bernard and O'Brien Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; NEUROTROPHIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN NODAL; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SOMATOMEDIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL RENEWAL; DOWN REGULATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PLURIPOTENT STEM CELL; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; EMBRYONIC STEM CELLS; GENE REGULATORY NETWORKS; HUMANS; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION;

IPS;

EID: 84876925256     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (173)

1. Adhikary, S. and Eilers, M. (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6(8): 635-645.
2. Ambrosetti, D. C., Basilico, C., et al. (1997). Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol 17(11): 6321-6329.
3. Amit, M., Carpenter, M. K., et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227(2): 271-278.
4. Amit, M., Shariki, C., et al. (2004). Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70(3): 837-845.
5. Androutsellis-Theotokis, A., Leker, R. R., et al. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442(7104): 823-826.
6. Armstrong, L., Hughes, O., et al. (2006). The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15(11): 1894-1913.
7. Assou, S., Le Carrour, T., et al. (2007). A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25(4): 961-973.
8. Atlasi, Y., Mowla, S. J., et al. (2008). OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 26(12): 3068-3074.
9. Avery, K., Avery, S., et al. (2008). Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. Stem Cells Dev 17(6): 1195-1205.
10. Avilion, A. A., Nicolis, S. K., et al. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17(1): 126-140.
11. Balzer, E. and Moss, E. G. (2007). Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol 4(1): 16-25.
12. Beattie, G. M., Lopez, A. D., et al. (2005). Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23(4): 489-495.
13. Bendall, S. C., Stewart, M. H., et al. (2007). IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448(7157): 1015-1021.
14. Besser, D. (2004). Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279(43): 45076-4584.
15. Boyer, L. A., Lee, T. I., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6): 947-956.
16. Brimble, S. N., Sherrer, E. S., et al. (2007). The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 25(1): 54-62.
17. Brons, I. G., Smithers, L. E., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448(7150): 191-195.
18. Burdon, T., Chambers, I., et al. (1999). Signaling mechanismsregulatingself-renewaland differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 165(3-4): 131-143.
19. Burdon, T., Smith, A., et al. (2002). Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 12(9): 432-438.
20. Burdon, T., Stracey, C., et al. (1999). Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 210(1): 30-43.
21. Cadigan, K. M. and Liu, Y. I., (2006). Wnt signaling: complexity at the surface. J Cell Sci 119(Pt 3): 395-402.
22. Cartwright, P., McLean, C., et al. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132(5): 885-896.
23. Chambers, I., Colby, D., et al. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113(5): 643-655.
24. Chambers, I., Silva, J., et al. (2007). Nanog safeguards pluripotency and mediates germline development. Nature 450(7173): 1230-1234.
25. Chan, K. K., Zhang, J., et al. (2009). KLF4 and PBX1 Directly Regulate NANOG Expression in Human Embryonic Stem Cells. Stem Cells 27(9): 2114-2125.
26. Charron, J., Malynn, B. A., et al. (1992). Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 6(12A): 2248-2257.
27. Chen, X., Xu, H., et al. (2008). Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133(6): 1106-1117.
28. Cheon, S. H., Kim, S. J., et al. (2005). Defined Feeder-FreeCultureSystemofHuman Embryonic Stem Cells. Biol Reprod 74(3): 611.
29. Chew, J. L., Loh, Y. H., et al. (2005). Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25(14): 6031-6046.
30. Chun, J., Goetzl, E. J., et al. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature. Pharmacol Rev 54(2): 265-269.
31. Claassen, D. A., Desler, M. M., et al. (2009). ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Mol Reprod Dev 76(8): 722-732.
32. D'Amour, K. A., Agulnick, A. D., et al. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23(12): 1534-1541.
33. Daheron, L., Opitz, S. L., et al. (2004). LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22(5): 770-778.
34. Damoiseaux, R., Sherman, S. P., et al. (2008). IntegratedChemicalGenomicsReveals Modifiers of Survival in Human Embryonic Stem Cells. Stem Cells 27(3): 533-542.
35. Darr, H. and Benvenisty N. (2009). Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells 27(2): 352-362.
36. Darr, H., Mayshar, Y., et al. (2006). Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133(6): 1193-1201.
37. Davidson, K. C., Jamshidi, P., et al. (2007). Wnt3a regulates survival, expansion, and maintenance of neuralprogenitorsderivedfromhuman embryonic stem cells. Mol Cell Neurosci 36(3): 408-415.
38. Davis, A. C., Wims, M., et al. (1993). A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7(4): 671-682.
39. Delrieu, I. (2000). The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett 468(1): 6-10.
40. Diecke, S., Quiroga-Negreira, A., et al. (2008). FGF2 signaling in mouse embryonic fibroblasts is crucial for self-renewal of embryonic stem cells. Cells Tissues Organs 188(1-2): 52-61.
41. Dravid, G., Ye, Z., et al. (2005). Defining the Role of Wnt/{beta}-Catenin Signaling in the Survival, Proliferation, and Self-Renewal of Human Embryonic Stem Cells. Stem Cells 23(10): 1489-1501.
42. Dvorak, P., Dvorakova, D., et al. (2005). Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Stem Cells 23(8): 1200-1211.
43. Eilers, M. and Eisenman, R. N. (2008). Myc's broad reach. Genes Dev 22(20): 2755-2766.
44. Ellis, P., Fagan, B. M., et al. (2004). SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 26(2-4): 148-165.
45. Ema, M., Mori, D., et al. (2008). Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3(5): 555-567.
46. Evans, P. M. and Liu, C., (2008). Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) 40(7): 554-564.
47. Feng, B., Ng, J. H., et al. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4(4): 301-12.
48. Fong, H., Hohenstein, K. A., et al. (2008). Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26(8): 1931-1938.
49. Ghaleb, A. M., Nandan, M. O., et al. (2005). Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15(2): 92-96.
50. Ginis, I., Luo, Y., et al. (2004). Differences between human and mouse embryonic stem cells. Dev Biol 269(2): 360-380.
51. Gotoh, N. (2009). Control of stemness by fibroblast growth factor signaling in stem cells and cancer stem cells. Curr Stem Cell Res Ther 4(1): 9-15.
52. Guo, Y., Costa, R., et al. (2002). The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci U S A 99(6): 3663-3667.
53. Harb, N., Archer, T. K., et al. (2008). The Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells. PLoS ONE 3(8): e3001.
54. Hasegawa, K., Fujioka, T., et al. (2006). A method for the selection of human embryonic stem cell sub-lines with high replating efficiency after single cell dissociation. Stem Cells 24(12): 2649-2660.
55. Hatano, S. Y., Tada, M., et al. (2005). Pluripotential competence of cells associated with Nanog activity. Mech Dev 122(1): 67-79.
56. Heng, B. C. (2009). Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell 41(5): 376-380.
57. Hohenstein, K. A., Pyle, A. D., et al. (2008). Nucleofection mediates high-efficiency stable gene knockdown and transgene expression in human embryonic stem cells. Stem Cells 26(6): 1436-1443.
58. Humphrey, R. K., G. M. Beattie, et al. (2004). Maintenanceofpluripotencyinhuman embryonic stem cells is STAT3 independent. StemCells22(4): 522-30.
59. Hyslop,L., Stojkovic, M., et al. (2005). Downregulationof NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23(8): 1035-1043.
60. Inniss, K. and Moore, H., (2006). Mediation of apoptosis and proliferation of human embryonic stem cells by sphingosine-1-phosphate. Stem Cells Dev 15(6): 789-796.
61. Itoh, N. and Ornitz, D. M. (2004). Evolution of the Fgf and Fgfr gene families. Trends Genet 20(11): 563-569.
62. Itsykson, P., Ilouz, N., et al. (2005). Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol Cell Neurosci 30(1): 24-36.
63. Ivanova, N., Dobrin, R., et al. (2006). Dissecting self-renewalinstemcellswithRNA interference. Nature 442(7102): 533-538.
64. James, D., Levine, A. J., et al. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132(6): 1273-1282.
65. Jiang, J., Chan, Y. S., et al. (2008). A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10(3): 353-360.
66. Kang, H. B., Kim, J. S., et al. (2005). Basic fibroblast growth factor activates ERK and induces c-fos in human embryonic stem cell line MizhES1. Stem Cells Dev 14(4): 395-401.
67. Katoh, M. (2006). CER1 is a common target of WNT and NODAL signaling pathways in human embryonic stem cells. Int J Mol Med 17(5): 795-799.
68. Kendall, S. D., Adam, S. J., et al. (2006). Genetically engineered human cancer models utilizing mammalian transgene expression. Cell Cycle 5(10): 1074-1079.
69. Kim, J., Chu, J., et al. (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132(6): 1049-1061.
70. Klimanskaya, I., Chung, Y., et al. (2005). Human embryonic stem cells derived without feeder cells. Lancet 365(9471): 1636-1641.
71. Knoepfler, P. S., Zhang, X. Y., et al. (2006). Myc influences global chromatin structure. EMBO J 25(12): 2723-2734.
72. Kondoh, H., Uchikawa, M., et al. (2004). Interplay of Pax6 and SOX2 in lens development as a paradigm of genetic switch mechanisms for cell differentiation. Int J Dev Biol 48(8-9): 819-827.
73. Kopp, J. L., Ormsbee, B. D., et al. (2008). Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26(4): 903-911.
74. Krawetz, R. J., Li, X., et al. (2009). Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays 31(3): 336-343.
75. Kunath, T., Saba-El-Leil, M. K., et al. (2007). FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134(16): 2895-2902.
76. Kuroda, T., Tada, M., et al. (2005). Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25(6): 2475-2485.
77. Lee, J., Kim, H. K., et al. (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 281(44): 33554-33565.
78. Letamendia, A., Labbe, E., et al. (2001). Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 83-A Suppl 1(Pt 1): S31-S39.
79. Levenstein, M. E., Ludwig, T. E., et al. (2006). Basic FGF Support of Human Embryonic Stem Cell Self-Renewal. Stem Cells 24(3): 568-574.
80. Li, J., Pan, G., et al. (2007). A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells. J Biol Chem 282(27): 19481-19492.
81. Li, J., Wang, G., et al. (2007). MEK/ERK signaling contributes to the maintenance of human embryonic stemcellself-renewal. Differentiation 75(4): 299-307.
82. Li, M., Pevny, L., et al. (1998). Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 8(17): 971-974.
83. Li, X., Krawetz, R., et al. (2009). ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Hum Reprod 24(3): 580-589.
84. Li, X., Meng, G., et al. (2008). The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stemcells following cryopreservation. Stem Cells Dev 17(6): 1079-1085.
85. Li, Y., McClintick, J., et al. (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105(2): 635-637.
86. Liu, L., Leaman, D., et al. (1997). Silencing of the gene for the alpha-subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4. Mol Endocrinol 11(11): 1651-1658.
87. Liu, L. and Roberts, R. M., (1996). Silencing of the gene for the beta subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4. J Biol Chem 271(28): 16683-16689.
88. Lu, B., P. Pang, T., et al. (2005). The yin and yang of neurotrophin action. Nat Rev Neurosci 6(8): 603-614.
89. Ludwig, T. E., Levenstein, M. E., et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24(2):185-187.
90. Masui, S., Nakatake, Y., et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9(6): 625-635.
91. Matin, M. M., Walsh, J. R., et al. (2004). Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22(5): 659-668.
92. Mayshar, Y., Rom, E., et al. (2008). Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells 26(3): 767-774.
93. McConnell, B. B., Ghaleb, A. M., et al. (2007). The diverse functions of Kruppel-like factors 4 and 5 inepithelial biology andpathobiology. Bioessays 29(6): 549-557.
94. McLean, A. B., D'Amour, K. A., et al. (2007). Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 25(1): 29-38.
95. Mitsui, K., Tokuzawa, Y., et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5): 631-642.
96. Miyazawa, K., Shinozaki, M., et al. (2002). Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7(12): 1191-1204.
97. Moss, E. G., Lee, R. C., et al. (1997). The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88(5): 637-646.
98. Nakagawa, M., Koyanagi, M., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26(1): 101-106.
99. Nakatake, Y., Fukui, N., et al. (2006). Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol Cell Biol 26(20): 7772-7782.
100. Naz, R. K., Kumar, G., et al. (1994). Expression and role of c-myc protooncogene in murine preimplantation embryonic development. J Assist Reprod Genet 11(4): 208-216.
101. Nichols, J., Zevnik, B., et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3): 379-391.
102. Nishimoto, M., Fukushima, A., et al. (1999). The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol 19(8): 5453-5465.
103. Nishimoto, M., Miyagi, S., et al. (2005). Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus. Mol Cell Biol 25(12): 5084-5094.
104. Niwa, H., Miyazaki, J., et al. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24(4): 372-376.
105. Niwa, H., Toyooka, Y., et al. (2005). Interaction betweenOct3/4andCdx2determines trophectoderm differentiation. Cell 123(5): 917-929.
106. Okamoto, K., Okazawa, H., et al. (1990). A novel octamerbindingtranscriptionfactoris differentially expressed in mouse embryonic cells. Cell 60(3): 461-472.
107. Okuda, A., Fukushima, A., et al. (1998). UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J 17(7): 2019-2032.
108. Paria, B. C., Dey, S. K., et al. (1992). Antisense c-myc effects on preimplantation mouse embryo development. Proc Natl Acad Sci U S A 89(21): 10051-10055.
109. Patel, J. H., Loboda, A. P., et al. (2004). Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 4(7): 562-568.
110. Pebay, A., Wong, R. C., et al. (2005). Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells 23(10): 1541-1548.
111. Pera, M. F., Andrade, J., et al. (2004). Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J Cell Sci 117(Pt 7): 1269-1280.
112. Pera, M. F., Andrade, J., et al. (2004). Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J Cell Sci 117(Pt 7): 1269-1280.
113. Pera, M. F., Reubinoff, B., et al. (2000). Human embryonic stem cells. J Cell Sci 113 (Pt 1): 5-10.
114. Pesce, M. and Scholer, H. R., (2001). Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19(4): 271-278.
115. Peter, M. E. (2009). Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8(6): 843-852.
116. Pitson, S. M. and Pebay, A., (2009). Regulation of stem cell pluripotency and neural differentiation by lysophospholipids. Neurosignals 17(4): 242-254.
117. Polesskaya, A., Cuvellier, S., et al. (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev 21(9): 1125-1138.
118. Pyle, A. D., Lock, L. F., et al. (2006). Neurotrophins mediate human embryonic stem cell survival. Nat Biotechnol 24(3): 344-350.
119. Reissmann, E., Jornvall, H., et al. (2001). The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 15(15): 2010-2022.
120. Reubinoff, B. E., Pera, M. F., et al. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18(4): 399-404.
121. Rho, J. Y., Yu, K., et al. (2006). Transcriptional profiling of the developmentally important signalling pathways in human embryonic stem cells. Hum Reprod 21(2): 405-412.
122. Richards, M., Tan, S. P., et al. (2004). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22(1): 51-64.
123. Rodda, D. J., Chew, J. L., et al. (2005). Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280(26): 24731-24737.
124. Rosner, M. H., Vigano, M. A., et al. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345(6277): 686-692.
125. Rowland, B. D., Bernards, R., et al. (2005). The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7(11): 1074-1082.
126. Rowland, B. D. and Peeper, D. S., (2006). KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6(1): 11-23.
127. Sato, N., Meijer, L., et al. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10(1): 55-63.
128. Sato, N., Sanjuan, I. M., et al. (2003). Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 260(2): 404-413.
129. Schlessinger, J. (2004). Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306(5701): 1506-1507.
130. Scholer, H. R., Balling, R., et al. (1989). Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J 8(9): 2551-2557.
131. Segre, J. A., Bauer, C. et al. (1999). Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22(4): 356-360.
132. Shi, Y. and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6): 685-700.
133. Shimozaki, K., Nakashima, K., et al. (2003). Involvement of Oct3/4 in the enhancement of neuronaldifferentiationofEScellsin neurogenesis-inducing cultures. Development 130(11): 2505-2512.
134. Sperger, J. M., Chen, X., et al. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 100(23): 13350-13355.
135. Sridharan, R., Tchieu, J., et al. (2009). Role of the murine reprogramming factors in the induction of pluripotency. Cell 136(2): 364-377.
136. Stachowiak, M. K., Fang, X., et al. (2003). Integrative nuclear FGFR1 signaling (INFS) as a part of a universal feed-forward-and-gate signaling module that controls cell growth and differentiation. J Cell Biochem 90(4): 662-691.
137. Stanton, B. R., Perkins, A. S., et al. (1992). Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6(12A): 2235-2247.
138. Sumi, T., Tsuneyoshi, N., et al. (2007). Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene 26(38): 5564-5576.
139. Suzuki, A., Raya, A., et al. (2006). Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci U S A 103(27): 10294-10299.
140. Takahashi, K., Tanabe, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5): 861-872.
141. Takahashi, K. and Yamanaka, S., (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663-676.
142. Takeda, J., Seino, S., et al. (1992). Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20(17): 4613-4620.
143. Takuwa, Y., Takuwa, N., et al. (2002). The edg familygprotein-coupledreceptorsfor lysophospholipids: their signaling properties and biological activities. J Biochem (Tokyo) 131(6): 767-771.
144. Thomson, J. A., Itskovitz-Eldor, J., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282(5391): 1145-1147.
145. Tokuzawa, Y., Kaiho, E., et al. (2003). Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol 23(8): 2699-2708.
146. Tomioka, M., Nishimoto, M., et al. (2002). Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 30(14): 3202-3213.
147. Vallier, L., Alexander, M., et al. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118(Pt 19): 4495-4509.
148. Vallier, L., Reynolds, D., et al. (2004). Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 275(2): 403-421.
149. Vallier, L., Touboul, T., et al. (2009). Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 4(6): e6082.
150. Varelas, X., Sakuma, R., et al. (2008). TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10(7): 837-848.
151. Vermeulen, K., Berneman, Z. N., et al. (2003). Cell cycle and apoptosis. Cell Prolif 36(3): 165-175.
152. Viswanathan, S. R., Daley, G. Q., et al. (2008). Selective blockade of microRNA processing by Lin28. Science 320(5872): 97-100.
153. Walsh, J. and Andrews, P. W., (2003). Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. Apmis 111(1): 197-210; discussion 210-1.
154. Wang, G., Zhang, H., et al. (2005). Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 330(3): 934-942.
155. Wang, J., Rao, S., et al. (2006). A protein interaction network for pluripotency of embryonic stem cells. Nature 444(7117): 364-368.
156. Wang, L., Li, L., et al. (2005). Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood 105(12): 4598-4603.
157. Watanabe, K., Ueno, M., et al. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25(6): 681-686.
158. Wernig, M., Meissner, A., et al. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2(1): 10-12.
159. Wong, R. C., Tellis, I., et al. (2007). Anti-apoptotic effect of sphingosine-1-phosphate and platelet-derived growth factor in human embryonic stem cells. Stem Cells Dev 16(6): 989-1001.
160. Xiao, L., Yuan, X., et al. (2006). Activin A maintains self-renewal and regulates FGF, Wnt and BMP pathways in human embryonic stem cells. Stem Cells 24(6): 1476-1486.
161. Xu, B., Zhang, K., et al. (2009). Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells. RNA 15(3): 357-361.
162. Xu, C., Inokuma, M. S., et al. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19(10): 971-974.
163. Xu, C., Rosler, E., et al. (2005). Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 23(3): 315-323.
164. Xu, R. H., X. Chen, et al. (2002). BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20(12): 1261-1214.
165. Xu, R. H., Peck, R. M., et al. (2005). Basic FGF and suppressionofBMPsignalingsustain undifferentiated proliferation of human ES cells. Nat Methods 2(3): 185-190.
166. Xu, R. H., Sampsell-Barron, T. L., et al. (2008). NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3(2): 196-206.
167. Yao, S., Chen, S., et al. (2006). Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci U S A 103(18): 6907-6912.
168. Ying, Q. L., Nichols, J., et al. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115(3): 281-292.
169. Yu, J., Vodyanik, M. A., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858): 1917-1920.
170. Yuan, H., Corbi, N., et al. (1995). Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 9(21): 2635-2645.
171. Zaehres, H., Lensch, M. W., et al. (2005). High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23(3): 299-305.
172. Zeineddine, D., Papadimou, E., et al. (2006). Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell 11(4): 535-546.
173. Zhao, S., Nichols, J., et al. (2004). SoxB transcription factors specify neuroectodermal lieage choice in ES cells. Mol Cell Neurosci 27(3): 332-342.